Israel: 13% bệnh nhân COVID-19 nhập viện có triệu chứng thần kinh nặng

Trong số hơn 16.000 bệnh nhân mắc COVID-19 nhập viện tại Israel, có tới 13% phát triển các triệu chứng thần kinh nghiêm trọng, phổ biến nhất là bệnh não.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chi phí chiến sự Iran của Mỹ vượt 47 tỷ USD

Chi phí chiến sự Iran của Mỹ vượt 47 tỷ USD

Thế giới
(Baothanhhoa.vn) - Dữ liệu mới nhất từ Lầu Năm Góc tính đến ngày 16/10 cho thấy chi phí quân sự của Mỹ trong cuộc chiến với Iran đã vượt mốc 47 tỷ USD, trong đó phần lớn ngân sách được dùng vào việc thay thế các loại đạn dược và khí tài đã tiêu hao.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh